Global Contrast and Imaging Agents in Interventional X-ray Market - Industry Trends and Forecast to 2026

  • Medical Devices
  • Published Report
  • Jan 2019
  • Global
  • 194 Pages
  • No of Tables: 59
  • No of Figures: 155

Global Contrast and Imaging Agents in Interventional X-ray Market, By Agent Type (Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Gold Nanoparticle Contrast Agents, Others), Application (Cardiology, Gastroenterology, Neurology, Oncology, Urology, General Surgery), End User (Imaging Centers, Hospital, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Private Practices), Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa) - Industry Trends and Forecast to 2026

Contrast and imaging agents in interventional X-ray market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.

Contrast agents or media doesn’t permanently discolour internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered. Contrast agents or media help physicians diagnose medical conditions by improving the vision. The material is absorbed by the body or eliminated through urine or bowel movements. There are various ways to use contrast material such as swallowed (taken by mouth or orally), injected into a blood vessel (vein or artery; also called given intravenously or intra-arterially) and administered by enema (given rectally). Different types of contrast materials are available including Iodine-based and barium-sulphate compounds used majorly in X ray and CT, Gadolinium which is used in magnetic resonance (MR) imaging and many others.

Global contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.6% in the forecast period 2019 to 2026.

Segmentation: Global Contrast and Imaging Agents in Interventional X-ray Market

Global contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.

  • On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

    • In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.

  • On the basis of application, the market is segmented into cardiology, gastroenterology, neurology, oncology, urology and general Surgery. In 2019, cardiology segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.
  • On the basis of end user, the market is segmented into imaging centers, hospital, clinics, diagnostic center, ambulatory surgical centers and private practices. In 2019, imaging centers segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.

Competitive Analysis: Global Contrast and Imaging Agents in Interventional X-ray Market

Some of the major players operating in this market are General Electric Company, Bracco, Lantheus Medical Imaging, Inc., Guerbet, FUJIFILM VisualSonics Inc, Jodas Expoim, TAEJOON PHARM, Unijules Life Sciences Ltd., J.B.Chemicals & Pharmaceuticals Ltd., iMAX,  Novalek Pharmaceuticals Pvt. Ltd., Nano Therapeutics Pvt Ltd and among others.

Strategies:

  • In December2018, GE launched its e-learning portal at Lagos Garage Week 2018 in Nigeria. This would help thousands of Nigerians with advanced manufacturing training program.
  • In November 2018, GE and Dragos Industrial Controls Systems announced their collaboration. This would help the company to strengthen the industrial control systems.
  • In May 2018, Shanghai Pharmaceutical Group Co., Ltd. (China) and Bracco Imaging signed a collaboration agreement on the research and development activities in China. This strategy focused on the exploitation of the potentialities of Bracco Imaging microbubbles technology platform for supporting the development of new Shanghai Pharmaceuticals therapeutic products in the oncologic field.
  • In October 2017, Bracco Imaging acquired SurgVision (Netherlands). This acquisition helped the company to expand its innovative field of fluorescence imaging-guided surgery.
  • In July 2018, IBM Watson Health (Massachusetts) and Guerbet announced a joint agreement for developing an artificial intelligence software solution for supporting liver cancer diagnostics using MRI and CT imaging, and care. This would help the company in expanding their product portfolio.
  • In April 2018, Guerbet announced the acquisition of a microsphere technology which is developed by Occlugel (France) for strengthening its interventional imaging range.
  • In November 2018, Lantheus Holdings announced the presence of Mary Anne Heino who is the President and CEO of the company at the BMO Prescriptions for Success Healthcare Conference on December 12 in New York City.
  • In September 2018, Lantheus Holdings announced the presence of Mary Anne Heino who is the President and CEO and Robert Marshall who is the CFO and Treasurer of the company at the 2018 Cantor Fitzgerald Global Healthcare Conference on October 3 in New York City.
  • In October 2016, FUJIFILM VisualSonics Inc., received an award of commercial innovation of the year by WMIS. This award was given due to their continuous development of innovative products.

Research Methodology: Global Contrast and Imaging Agents in Interventional X-ray Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Radiologists and Cardiologists Doctors, Nurses, Medical practitioners, Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

LIST OF TABLES GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET

TABLE 1 TOTAL AGEING POPULATION IN TURKEY AND IRAN TABLE 2 NUMBER OF DIAGNOSTIC IMAGING EQUIPMENT IN CANADA (2007 & 2017) TABLE 3 RESEARCH AND DEVELOPMENT EXPENDITURE FOR COMPANIES (USD MILLION) (2016 & 2017) TABLE 4 AMOUNT OF CONTRAST MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT TABLE 5 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 6 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, IODINATED CONTRAST MEDIA, BY REGION, 2017-2026 (USD MILLION) TABLE 7 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BARIUM-BASED CONTRAST MEDIA, BY REGION, 2017-2026 (USD MILLION) TABLE 8 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, MICROBUBBLE CONTRAST MEDIA, BY REGION, 2017-2026 (USD MILLION) TABLE 9 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, GOLD NANOPARTICLE CONTRAST AGENTS, BY REGION, 2017-2026 (USD MILLION) TABLE 10 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, OTHERS, BY REGION, 2017-2026 (USD MILLION) TABLE 11 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 12 GLOBAL CARDIOLOGY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 13 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, CARDIOLOGY, BY REGION, 2017-2026 (USD MILLION) TABLE 14 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, GASTROENTEROLOGY, BY REGION, 2017-2026 (USD MILLION) TABLE 15 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, NEUROLOGY, BY REGION, 2017-2026 (USD MILLION) TABLE 16 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, ONCOLOGY, BY REGION, 2017-2026 (USD MILLION) TABLE 17 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, UROLOGY, BY REGION, 2017-2026 (USD MILLION) TABLE 18 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, GENERAL SURGERY, BY REGION, 2017-2026 (USD MILLION) TABLE 19 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 20 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, IMAGING CENTERS, BY REGION, 2017-2026 (USD MILLION) TABLE 21 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, HOSPITAL, BY REGION, 2017-2026 (USD MILLION) TABLE 22 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, CLINICS, BY REGION, 2017-2026 (USD MILLION) TABLE 23 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, DIAGNOSTIC CENTER, BY REGION, 2017-2026 (USD MILLION) TABLE 24 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, AMBULATORY SURGICAL CENTERS, BY REGION, 2017-2026 (USD MILLION) TABLE 25 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, PRIVATE PRACTICES, BY REGION, 2017-2026 (USD MILLION) TABLE 26 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 27 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 28 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 29 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 30 NORTH AMERICA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 31 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 32 U.S. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 33 U.S. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 34 U.S. CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 35 U.S. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 36 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 37 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 38 CANADA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 39 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 40 MEXICO CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 41 MEXICO CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 42 MEXICO CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 43 MEXICO CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 44 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 45 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 46 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 47 EUROPE CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 48 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 49 GERMANY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 50 GERMANY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 51 GERMANY CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 52 GERMANY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 53 U.K. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 54 U.K. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 55 U.K. CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 56 U.K. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 57 FRANCE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 58 FRANCE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 59 FRANCE CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 60 FRANCE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 61 ITALY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 62 ITALY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 63 ITALY CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 64 ITALY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 65 SPAIN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 66 SPAIN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 67 ITALY CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 68 SPAIN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 69 SWITZERLAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 70 SWITZERLAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 71 SWITZERLAND CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 72 SWITZERLAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 73 NETHERLANDS CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 74 NETHERLANDS CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 75 NETHERLANDS CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 76 NETHERLANDS CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 77 RUSSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 78 RUSSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 79 RUSSIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 80 RUSSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 81 BELGIUM CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 82 BELGIUM CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 83 BELGIUM CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 84 BELGIUM CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 85 TURKEY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 86 TURKEY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 87 TURKEY CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 88 TURKEY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 89 BELGIUM CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 90 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 91 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 92 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 93 ASIA PACIFIC CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 94 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 95 CHINA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 96 CHINA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 97 CHINA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 98 CHINA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 99 JAPAN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 100 JAPAN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 101 JAPAN CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 102 JAPAN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 103 INDIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 104 INDIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 105 INDIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 106 INDIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 107 AUSTRALIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 108 AUSTRALIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 109 AUSTRALIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 110 AUSTRALIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 111 SOUTH KOREA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 112 SOUTH KOREA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 113 SOUTH KOREA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 114 SOUTH KOREA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 115 SINGAPORE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 116 SINGAPORE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 117 SINGAPORE CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 118 SINGAPORE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 119 MALAYSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 120 MALAYSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 121 MALAYSIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 122 MALAYSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 123 INDONESIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 124 INDONESIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 125 INDONESIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 126 INDONESIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 127 THAILAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 128 THAILAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 129 THAILAND CARDIOLOGY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 130 THAILAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 131 PHILIPPINES CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 132 PHILIPPINES CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 133 PHILIPPINES CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 134 PHILIPPINES CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 135 REST OF ASIA-PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 136 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 137 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 138 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 139 SOUTH AMERICA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 140 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 141 BRAZIL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 142 BRAZIL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 143 BRAZIL CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 144 BRAZIL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 145 REST OF SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 146 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 147 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 148 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 149 MIDDLE EAST & AFRICA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 150 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 151 SOUTH AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) TABLE 152 SOUTH AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 153 SOUTH AFRICA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 154 SOUTH AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 155 REST OF MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION)
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE